drugset / Trial / NCT01369719

Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload

NCT01369719

RandomizedParallel-groupDouble-blindTreatment

Summary

Thalassemic patients often suffer from iron overload due to frequent blood transfusion. Oral iron chelators reduce iron overload in transfusion dependent patients. The aim of this study is to compare the efficacy and safety of osveral and desferal in transfusional iron overload patients with β-Thalassemia and intermediate Thalassemia in Bandarabbas.

Timeline

Start
2010-02
Primary completion
2011-01
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Deferasirox Unknown 20 mg/kg Oral
Comparator Deferoxamine Other / unclassified 40 mg/kg Subcutaneous
Comparator Deferoxamine Other / unclassified 50 mg/kg Subcutaneous